In contrast, gain-of-function (GOF) causes tumor cells to overaccumulate mutated p53 protein.These mutated p53 proteins not only eliminate the tumor inhibitory function of wild-type p53, but also endow mutant proteins with new activities, which can actively promote all stages of tumor progression and increase resistance to anticancer therapy (53). The gene discussed is TP53; the disease is neoplasm.